[1]
R. P. Dash, R. J. Babu, and N. R. Srinivas, “Non-alcoholic Steatohepatitis (NASH) Drug Discovery – Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development”, J Pharm Pharm Sci, vol. 21, no. 1, pp. 481–495, Nov. 2018.